|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07K 5/087 | (2006.01) |
| A61K 38/07 | (2006.01) | ||
| A61K 38/06 | (2006.01) | ||
| C07K 5/103 | (2006.01) | ||
| C07K 5/02 | (2006.01) |
| (11) | Number of the document | 1781688 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05784484.7 |
| Date of filing the European patent application | 2005-08-08 | |
| (97) | Date of publication of the European application | 2007-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2011-01-19 |
| (46) | Date of publication of the claims translation | 2011-06-27 |
| (86) | Number | PCT/US2005/028246 |
| Date | 2005-08-08 |
| (87) | Number | WO 2006/017842 |
| Date | 2006-02-16 |
| (30) | Number | Date | Country code |
| 599401 P | 2004-08-06 | US | |
| 610001 P | 2004-09-14 | US | |
| 106879 | 2005-04-14 | US |
| (72) |
SMYTH, Mark, S., US
LAIDIG, Guy, J., US
|
| (73) |
Onyx Therapeutics, Inc.,
249 E. Grand Avenue, South San Francisco, CA 94080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Junginiai, skirti proteasomos fermentų slopinimui |
| COMPOUNDS FOR PROTEASOME ENZYME INHIBITION |
| Payment date | Validity (years) | Amount | |
| 2024-07-23 | 347.00 EUR |